Company Shandong Xinhua Pharmaceutical Company Limited

Equities

719

CNE100000411

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
5.45 HKD +0.74% Intraday chart for Shandong Xinhua Pharmaceutical Company Limited +3.81% -5.71%

Business Summary

SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.

Number of employees: 7,104

Sales per Business

HKD in Million2022Weight2023Weight Delta
Preparation
56.2 %
3,714 42.6 % 5,033 56.2 % +35.53%
Chemical Raw Material
38.9 %
3,688 42.3 % 3,478 38.9 % -5.71%
Pharmaceutical Intermediates and Other Products
27.9 %
1,323 15.2 % 2,499 27.9 % +88.87%
Offset
-23.0 %
0 0.0 % -2,059 -23.0 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
China (including Hong Kong)
73.2 %
5,696 65.3 % 6,556 73.2 % +15.10%
Europe
12.6 %
1,234 14.1 % 1,131 12.6 % -8.35%
Americas
9.4 %
1,187 13.6 % 844 9.4 % -28.89%
Others
4.7 %
608 7.0 % 420 4.7 % -30.94%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 487,407,635 239,031,750 ( 49.04 %) 0 60.55 %
Stock B 1 195,000,000 174,172,200 ( 89.32 %) 0

Shareholders

NameEquities%Valuation
eQ Varainhoito Oy
0.5333 %
1,040,000 0.5333 % 714 906 $
AXA Investment Managers Asia Ltd.
0.0385 %
74,979 0.0385 % 51 541 $
Dimensional Fund Advisors Ltd.
0.0277 %
53,975 0.0277 % 37 103 $
JPMorgan Asset Management (China) Co Ltd.
0.007179 %
14,000 0.007179 % 9 624 $
DFA Australia Ltd.
0.005802 %
11,314 0.005802 % 7 777 $
HuaAn Fund Management Co., Ltd.
0.002051 %
4,000 0.002051 % 2 750 $
NameEquities%Valuation
Shandong State-Owned Asset Sup. & Adm. Commission
54.03 %
241,956,080 54.03 % 551 M $
Wei Fang
1.611 %
7,213,386 1.611 % 16 M $
Haitao Yu
0.3094 %
1,385,400 0.3094 % 3 M $
Xu Zheng
0.2427 %
1,086,700 0.2427 % 2 M $
850,000 0.1898 % 2 M $
China Asset Management Co., Ltd.
0.0876 %
392,200 0.0876 % 893 208 $
China Southern Asset Management Co., Ltd.
0.0776 %
347,300 0.0776 % 790 951 $
Ning Hou
0.0734 %
328,800 0.0734 % 748 819 $
291,950 0.0652 % 664 896 $
Lie Xu
0.0652 %
291,950 0.0652 % 664 896 $
NameEquities%Valuation
Shandong State-Owned Asset Sup. & Adm. Commission
52.63 %
20,827,800 52.63 % 47 M $
183,150 0.4628 % 417 111 $
162,352 0.4103 % 369 745 $
133,200 0.3366 % 303 354 $
133,200 0.3366 % 303 354 $
Lie Xu
0.2794 %
110,550 0.2794 % 251 770 $
Wen Hui Xu
0.2032 %
80,400 0.2032 % 183 105 $

Company contact information

Shandong Xinhua Pharmaceutical Co., Ltd.

No. 1 Lutai Avenue Hi-tech Industry Development Zone

255086, Zibo

+86 53 3216 6666

http://www.xhzy.com
address Shandong Xinhua Pharmaceutical Company Limited(719)
  1. Stock Market
  2. Equities
  3. 719 Stock
  4. Company Shandong Xinhua Pharmaceutical Company Limited